tiprankstipranks
Trending News
More News >
Myriad Genetics (MYGN)
NASDAQ:MYGN

Myriad Genetics (MYGN) Revenue

Compare
420 Followers

Myriad Genetics Revenue

Myriad Genetics had a revenue of 205.70M in the quarter ending Sep 30, 2025, with -3.47%. This bring the company's revenue in the last twelve months to 825.30M, Increased -0.91%. In the fiscal year ending Dec 31, 2024, Myriad Genetics had annual revenue of 837.60M with 11.21% growth.
Revenue (ttm)
825.30M
Revenue Growth
0.21%
P/S Ratio
0.73
Revenue/Employee
$310,222
Employees
2,700
Market Cap
$610.55M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
837.60M84.40M+111.21%
Dec 31, 2023
753.20M74.80M+111.03%
Dec 31, 2022
678.40M-12.20M+98.23%
Dec 31, 2021
690.60M133.60M+123.99%
Dec 31, 2020
557.00M-81.60M+87.22%
Dec 31, 2019
638.60M-212.50M+75.03%
Dec 31, 2018
851.10M78.50M+110.16%
Dec 31, 2017
772.60M1.20M+100.16%
Dec 31, 2016
771.40M